Skip to content
Screener

Insulet PODD Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$64.67B+29.7%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$804.64M+30.9%
Medtronic logo
MedtronicMDT
$24.79B+4.1%
Beta Bionics logo
Beta BionicsBBNX
$231.03M-19.2%
Embecta Corp. logo
Embecta Corp.EMBC
$608.1M-5.5%
Opko Health logo
Opko HealthOPK
$500.24M-14.2%

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.23B-52.7%
Enterprise value$9.67B-52.3%
P/E24.6×-58.1×
P/S-5.2×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions, except share and per share data)June 30, 2026December 31, 2025
Accounts receivable trade, net588.7516.9
Inventories484.8452.6
Prepaid expenses and other current assets240.7228.3
Total current assets1,849.11,914.0
Property, plant and equipment, net858.6819.5
Other intangible assets, net115.1117.1
Goodwill51.651.6
Other assets290.8288.2

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's total current assets?
Insulet (PODD) reported total current assets of $1.85B in Q2 2026.
How has Insulet's total current assets changed year-over-year?
Insulet's total current assets decreased by 18.9% year-over-year, from $2.28B to $1.85B.
What is the long-term trend for Insulet's total current assets?
Over 5 years (2020 to 2025), Insulet's total current assets has grown at a 8.9% compound annual growth rate (CAGR), from $1.25B to $1.91B.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Insulet's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude